Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y014307 | OT |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | OT |
HCP called to report a patient may have inadvertently received a dose of PROQUAD that was beyond expiration on 04/02/2025. The HCP stated the PROQUAD's expiration date was "short-dated" after a temperature excursion on 01/02/2025 with a "short-date; The patient did not report any adverse issue or side effect; This spontaneous report was received from a Medical assistant and refers to a 4-year-old female patient. The patient's concurrent conditions, medical history, Concomitant medications, drug reactions or allergies were not reported. On 02-Jan-2025, a dose of Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y014307, expiration date: 18-Feb-2026) underwent a temperature excursion at 69 Fahrenheit (F) for 4 hours 20 minutes (product storage error). Therefore, the site shortened the expiration date of the vaccine to 02-Apr-2025. On this date, the patient was inadvertently vaccinated with the dose of Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y014307, expiration date: 18-Feb-2026) 0.5 mL (route of administration, anatomical location not provided) as prophylaxis (discrepant information, as the reporter stated that the dose was given beyond shortened expiration date). The patient did not report any adverse event issue or side effect from the administrated dose. No previous temperature excursions were reported.; Reporter's Comments: